Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EyePoint Pharmaceuticals Inc. sell Lokrim

Start price
€3.68
17.08.26 / 20%
Target price
-
17.08.27
Performance (%)
14.13%
Price
€11.40
14.08.26
Summary
This prediction is currently active. The SELL prediction by Lokrim currently has a performance of 14.13%. This prediction currently runs until 17.08.27. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w
EyePoint Pharmaceuticals Inc. 14.13%
iShares Core DAX® -0.046%
iShares Nasdaq 100 0.922%
iShares Nikkei 225® 3.014%
iShares S&P 500 -0.359%

According to Lokrim what are the pros and cons of EyePoint Pharmaceuticals Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren

Sell EyePoint Pharmaceuticals Inc.